⚠️ This provider averages 2.4K services per working day — physically unusual for an individual practitioner
Based on 6.0M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $55.1M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Their average markup ratio of 5.56x is significantly above the specialty median of 3.5x.
Averaging 2.4K services per working day raises questions about billing patterns.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 65% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $26.87 | $9.82 | 2.74x | $17.05 | $3.6M | 361.6K | 70 |
| 2015 | $65.18 | $7.19 | 9.07x | $57.99 | $3.8M | 531.7K | 61 |
| 2016 | $64.82 | $7.38 | 8.78x | $57.44 | $4.6M | 627.5K | 63 |
| 2017 | $63.47 | $7.32 | 8.67x | $56.15 | $4.2M | 578.1K | 64 |
| 2018 | $59.14 | $6.49 | 9.11x | $52.65 | $3.2M | 492.2K | 61 |
| 2019 | $59.89 | $7.66 | 7.82x | $52.23 | $5.3M | 687.5K | 73 |
| 2020 | $41.56 | $11.32 | 3.67x | $30.24 | $8.6M | 758.5K | 69 |
| 2021 | $45.60 | $12.08 | 3.77x | $33.52 | $9.3M | 771.9K | 71 |
| 2022 | $43.80 | $11.42 | 3.84x | $32.38 | $7.2M | 633.7K | 61 |
| 2023 | $38.23 | $10.15 | 3.77x | $28.08 | $5.3M | 520.7K | 64 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J2505 | Injection, pegfilgrastim, 6 mg | 1.8K | $5.2M | $3.0K | 5.16x |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 1.7M | $4.8M | $2.89 | 6.45x |
| J0897 | Injection, denosumab, 1 mg | 240.8K | $3.5M | $14.63 | 7.11x |
| J9022 | Injection, atezolizumab, 10 mg | 53.7K | $3.4M | $62.52 | 3.69x |
| J9271 | Injection, pembrolizumab, 1 mg | 71.2K | $3.0M | $41.94 | 3.02x |
| J9035 | Injection, bevacizumab, 10 mg | 55.0K | $3.0M | $54.14 | 5.93x |
| J1930 | Injection, lanreotide, 1 mg | 51.9K | $2.7M | $51.56 | 3.23x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 2.1K | $2.5M | $1.2K | 5.50x |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 78.3K | $2.4M | $31.14 | 5.23x |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 36.7K | $1.8M | $48.64 | 3.51x |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 2.0M | $1.7M | $0.85 | 20.72x |
| J9310 | Injection, rituximab, 100 mg | 2.8K | $1.7M | $612.11 | 6.12x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 17.7K | $1.6M | $87.74 | 3.91x |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 28.2K | $1.1M | $39.85 | 3.74x |
| J9299 | Injection, nivolumab, 1 mg | 49.4K | $1.1M | $22.60 | 4.14x |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 33.0K | $1.1M | $33.55 | 4.58x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 6.9K | $790.6K | $115.17 | 5.21x |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 14.0K | $765.2K | $54.69 | 2.98x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 70.7K | $749.1K | $10.59 | 3.55x |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 22.4K | $693.8K | $31.04 | 5.98x |
This provider submits charges 5.56 times higher than what Medicare actually pays.
A markup ratio of 5.56x means for every $100 Medicare pays, this provider initially charges $556. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Luke Dreisbach, M.D. | Rancho Mirage, CA | $77.2M | ✓ Clear |
| Ravi Rao, MD | Fresno, CA | $49.1M | ⚠️ Flagged |
| Michael Sherman, M.D., PHD | Walnut Creek, CA | $38.9M | ✓ Clear |
| Nerses Tchekmedyian, M.D. | Irvine, CA | $38.0M | ✓ Clear |
| Kishore Sehgal, M.D. | Hemet, CA | $36.2M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data